Identification of commonly altered genes between in major depressive disorder and a mouse model of depression

[1]  R. Cabeza,et al.  Present and Future , 2008 .

[2]  M. Yau,et al.  Role of Histone Acetylation and Methylation in Obesity , 2019, Current Pharmacology Reports.

[3]  Yoshifumi Watanabe,et al.  Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior , 2016, Biological Psychiatry.

[4]  Yoshifumi Watanabe,et al.  Disrupted orbitomedial prefrontal limbic network in individuals with later-life depression. , 2016, Journal of affective disorders.

[5]  Yukihiro Itoh,et al.  Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice , 2016, The Journal of Neuroscience.

[6]  F. Wright,et al.  Gene expression in major depressive disorder , 2016, Molecular Psychiatry.

[7]  M. Fukuda,et al.  Blood Transcriptomic Markers in Patients with Late-Onset Major Depressive Disorder , 2016, PloS one.

[8]  M. Ota,et al.  Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses , 2016, Scientific Reports.

[9]  E. Redei,et al.  The Promise of Biomarkers in Diagnosing Major Depression in Primary Care: the Present and Future , 2015, Current Psychiatry Reports.

[10]  T. Olczak,et al.  UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats)* , 2015, The Journal of Biological Chemistry.

[11]  Q. Gong,et al.  Depression, Neuroimaging and Connectomics: A Selective Overview , 2015, Biological Psychiatry.

[12]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[13]  N. Pomara,et al.  A review of the relationship between proinflammatory cytokines and major depressive disorder. , 2014, Journal of affective disorders.

[14]  B. Penninx,et al.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484) , 2014, Molecular Psychiatry.

[15]  R. Vitorino,et al.  Expression and functionality of histone H2A variants in cancer , 2014, Oncotarget.

[16]  Ning Sun,et al.  Microarray Profiling and Co-Expression Network Analysis of Circulating lncRNAs and mRNAs Associated with Major Depressive Disorder , 2014, PloS one.

[17]  S. Lam,et al.  YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway. , 2013, Cancer research.

[18]  Rui Mei,et al.  Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing , 2013, Molecular Psychiatry.

[19]  L. Sturiale,et al.  Mutations in SLC35A3 cause autism spectrum disorder, epilepsy and arthrogryposis , 2013, Journal of Medical Genetics.

[20]  Sudhir Gupta,et al.  Case Studies , 2013, Journal of Clinical Immunology.

[21]  Yoshifumi Watanabe,et al.  The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  C. Pariante,et al.  Depression pathogenesis and treatment: what can we learn from blood mRNA expression? , 2013, BMC Medicine.

[23]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[24]  John P. Rice,et al.  Dissecting the Genetic Heterogeneity of Depression Through Age at Onset , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  F. Al-Mohanna,et al.  Loss of ERLIN2 function leads to juvenile primary lateral sclerosis , 2012, Annals of neurology.

[26]  B. Baune,et al.  Neuroplastic changes in depression: A role for the immune system , 2012, Psychoneuroendocrinology.

[27]  J. Abrams,et al.  ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways , 2012, BMC Cancer.

[28]  W Gardner,et al.  Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression , 2012, Translational Psychiatry.

[29]  Wu Hong,et al.  Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder , 2012, PloS one.

[30]  B. Wiese,et al.  Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis. , 2012, Journal of affective disorders.

[31]  N. Dygalo,et al.  Increased Expression of the Anti-Apoptotic Protein Bcl-xL in the Brain is Associated with Resilience to Stress-Induced Depression-Like Behavior , 2012, Cellular and Molecular Neurobiology.

[32]  Yoshifumi Watanabe,et al.  Altered sirtuin deacetylase gene expression in patients with a mood disorder. , 2011, Journal of psychiatric research.

[33]  R. Roeder,et al.  The GAS41-PP2Cβ Complex Dephosphorylates p53 at Serine 366 and Regulates Its Stability* , 2011, The Journal of Biological Chemistry.

[34]  Takayoshi Suzuki,et al.  Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events , 2011, Neuron.

[35]  G. Churchill,et al.  Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models , 2010, Molecular Psychiatry.

[36]  C. Allis,et al.  Histone variants in metazoan development. , 2010, Developmental cell.

[37]  R. Kessler,et al.  Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. , 2010, The American journal of psychiatry.

[38]  S. Tafuri,et al.  Depressive and adjustment disorders – some questions about the differential diagnosis: case studies , 2010, Neuropsychiatric disease and treatment.

[39]  J. Henson,et al.  Plasticity , 2010, Neurology.

[40]  Yoshifumi Watanabe,et al.  Altered gene expression of histone deacetylases in mood disorder patients , 2009, Neuroscience Research.

[41]  Florian Holsboer,et al.  Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. , 2009, Archives of general psychiatry.

[42]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[43]  R. Wojcikiewicz,et al.  An Endoplasmic Reticulum (ER) Membrane Complex Composed of SPFH1 and SPFH2 Mediates the ER-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors* , 2009, Journal of Biological Chemistry.

[44]  Paolo Sassone-Corsi,et al.  Decoding the Epigenetic Language of Neuronal Plasticity , 2008, Neuron.

[45]  C. Ghelardini,et al.  An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown , 2008, Neuropharmacology.

[46]  Yoshifumi Watanabe,et al.  Altered expression of neurotrophic factors in patients with major depression. , 2008, Journal of psychiatric research.

[47]  Nicolas Stransky,et al.  Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. , 2008, Cancer research.

[48]  J. Roder,et al.  Beta N‐acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression‐like phenotype in mice , 2008, Genes, brain, and behavior.

[49]  C. Sotomayor,et al.  The Role of the Immune System , 2008 .

[50]  S. Robbins,et al.  Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER , 2006, Journal of Cell Science.

[51]  P. Giampietro,et al.  Evaluation of SLC35A3 as a candidate gene for human vertebral malformations , 2006, American journal of medical genetics. Part A.

[52]  Yoshifumi Watanabe,et al.  Reduced Glucocorticoid Receptor α Expression in Mood Disorder Patients and First-Degree Relatives , 2006, Biological Psychiatry.

[53]  Q. Ye,et al.  HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma , 2006, Oncogene.

[54]  Masaru Mimura,et al.  Reliability and validity of Japanese version of the Mini‐International Neuropsychiatric Interview , 2005, Psychiatry and clinical neurosciences.

[55]  F. McMahon,et al.  Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees , 2004, Biological Psychiatry.

[56]  C. Hahn,et al.  Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. , 1999, Bipolar disorders.

[57]  Y. Chiba,et al.  Molecular cloning and functional expression of the human Golgi UDP-N-acetylglucosamine transporter. , 1999, Journal of biochemistry.

[58]  U. Fischer,et al.  Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I. , 1997, Human molecular genetics.

[59]  M Keller,et al.  Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. , 1995, Archives of general psychiatry.

[60]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[61]  K. Mikoshiba.  Role of IP3 receptor signaling in cell functions and diseases. , 2015, Advances in biological regulation.

[62]  Michael J. Thompson,et al.  A selective overview , 2015 .

[63]  樋口 文宏.  State-dependent changes in the expression of DNA methyltransferases in mood disorder patients , 2013 .

[64]  F J Durgin,et al.  Depression in the elderly. , 1978, Comprehensive therapy.